|
Volumn 8, Issue 8, 2013, Pages
|
Successful crizotinib retreatment after crizotinib-induced interstitial lung disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANAPLASTIC LYMPHOMA KINASE;
CARBOPLATIN;
CRIZOTINIB;
DEXAMETHASONE;
DOCETAXEL;
GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;
LEVOFLOXACIN;
METHYLPREDNISOLONE;
PEMETREXED;
ADULT;
BONE METASTASIS;
BRAIN METASTASIS;
CANCER CHEMOTHERAPY;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
COUGHING;
DISEASE COURSE;
DRUG INDUCED DISEASE;
DRUG MEGADOSE;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
DYSPNEA;
FATIGUE;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENE REARRANGEMENT;
HUMAN;
HYPOXEMIA;
INTERSTITIAL LUNG DISEASE;
LUNG ADENOCARCINOMA;
LUNG METASTASIS;
NOTE;
PRIORITY JOURNAL;
REMISSION;
RESPIRATORY DISTRESS;
RETREATMENT;
SMOKING;
THORAX RADIOGRAPHY;
TREATMENT DURATION;
TREATMENT RESPONSE;
TUMOR REGRESSION;
ADENOCARCINOMA;
FEMALE;
HUMANS;
LUNG DISEASES, INTERSTITIAL;
LUNG NEOPLASMS;
MIDDLE AGED;
MUTATION;
ONCOGENE PROTEINS, FUSION;
PROTEIN KINASE INHIBITORS;
PYRAZOLES;
PYRIDINES;
RETREATMENT;
|
EID: 84880913544
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1097/JTO.0b013e318293dfc1 Document Type: Article |
Times cited : (30)
|
References (5)
|